Use of maximal sterile barriers during central venous catheter insertion: Clinical and economic outcomes

Clinical Infectious Diseases

Volumn 39, Issue 10, 2004, Pages 1441-1445

  Hu, Kent K ^a,d   Veenstra, David L ^a   Lipsky, Benjamin A ^a   Saint, Sanjay ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CONTAMINATION; CALCULATION; CATHETER INFECTION; CAUSE OF DEATH; CENTRAL VENOUS CATHETER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; INFECTION RISK; MODEL; PRIORITY JOURNAL; SAFETY; SENSITIVITY ANALYSIS;

CATHETERIZATION, CENTRAL VENOUS; COSTS AND COST ANALYSIS; HUMANS; INFECTION; STERILIZATION;

EID: 8744310295     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/425309     Document Type: Article

References (29)

1. Adal KA, Farr BM. Central venous catheter-related infections: a review. Nutrition 1996; 12:208-13.
2. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
3. McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 2003; 37:65-72.
4. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002; 30:476-89.
5. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402.
6. National Nosocomial Infections Surveillance System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26:522-33.
7. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996; 17:438-73.
8. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91(Suppl 3B):197S-205S.
9. Farr BM. Preventing vascular catheter-related infections: current controversies. Clin Infect Dis 2001; 33:1733-8.
10. Darouiche RO. Prevention of vascular catheter-related infections. Neth J Med 1999; 55:92-9.
11. Raad I. Intravascular catheter-related infections. Lancet 1998; 351: 893-8.
12. Sitges-Serra A. Strategies for prevention of catheter-related bloodstream infections. Support Care Cancer 1999; 7:391-5.
13. Hu KK, Lipsky BA, Veenstra DL, Saint S. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control 2004; 32:142-6.
14. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000; 132:641-8.
15. Pearson ML, Abrutyn E. Reducing the risk for catheter-related infections: a new strategy. Ann Intern Med 1997; 127:304-6.
16. Maki DG, Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia. Infect Control Hosp Epidemiol 1994; 15: 227-30.
17. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554-60.
18. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281:261-7.
19. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol 2000; 21:375-80.
20. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:231-8.
21. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 2003; 37:764-71.
22. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-101.
23. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia: mortality and hospital stay. Ann Intern Med 1989; 110: 9-16.
24. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997; 127:257-66.
25. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991; 100: 164-7.
26. Tacconelli E, Tumbarello M, Pittiruti M, et al. Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Eur J Clin Microbiol Infect Dis 1997; 16:203-9.
27. Pemberton LB, Ross V, Cuddy P, Kremer H, Fessier T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 1996; 131: 986-9.
28. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16:778-84.
29. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136:792-801.